WITNESSETH:Employment Agreement • March 29th, 2002 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances • Washington
RECITALS:Employment Agreement • March 29th, 2002 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances
WITNESSETH:Employment Agreement • March 29th, 2002 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances • Washington
EXHIBIT 10.21.1 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION SECOND AMENDED AND RESTATED...License and Supply Agreement • March 29th, 2002 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.26.1 November 13, 2001 Bay City Capital LLC 750 Battery Street, Suite 600 San Francisco, CA 94111 Attn: Sanford S. Zweifach Re: Extension of Letter Agreement between Epoch Biosciences, Inc. and Bay City Capital BD LLC Dear Mr. Zweifach:...Epoch Biosciences Inc • March 29th, 2002 • In vitro & in vivo diagnostic substances
Reference is made to the Letter Agreement between Epoch Biosciences, Inc. (the "Company") and Bay City Capital BD, LLC., (the "Advisor") dated November 7, 2000 with respect to the engagement of Advisor by the Company (the "Agreement").
BACKGROUNDFirst Side Agreement • March 29th, 2002 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances
